Table 1.
Correlations of WNT7A with clinical characteristics in PDAC patients.
Characteristics | WNT7A Expression | |||
---|---|---|---|---|
Total | High | Low | P value | |
(n = 100) | (n = 64) | (n = 36) | (χ2 test) | |
Age(years) | 1.000 | |||
<60 | 47 | 30 | 17 | |
≥60 | 53 | 34 | 19 | |
Gender | 0.426 | |||
Male | 63 | 42 | 21 | |
Female | 37 | 22 | 15 | |
Tumor location | 1.000 | |||
Head | 60 | 38 | 22 | |
Body/tail | 40 | 26 | 14 | |
Size | 0.541 | |||
≤3 cm | 15 | 9 | 6 | |
>3 cm | 83 | 53 | 30 | |
Tumor differentiation | 1.000 | |||
Well | 69 | 44 | 25 | |
Moderate/poor | 31 | 20 | 11 | |
T classification | 0.531 | |||
T1/2 | 78 | 50 | 28 | |
T3/4 | 20 | 12 | 8 | |
N classification | 0.033 | |||
Absent | 55 | 29 | 26 | |
Present | 39 | 30 | 9 | |
M classification | 0.535 | |||
Absent | 98 | 62 | 36 | |
Present | 2 | 2 | 0 | |
AJCC stage | 0. 535 | |||
Stage I/II | 98 | 62 | 36 | |
Stage III/IV | 2 | 2 | 0 | |
Neural invasion | 0.341 | |||
Absent | 58 | 34 | 24 | |
Present | 40 | 29 | 11 |
AJCC staging is according to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system. The bold number represents the p-values with significant differences. P value was calculated by χ2 test or Fisher’s exact test.